{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:48Z","timestamp":1773273648128,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Techniques in Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.tvir.2026.101100","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:31:29Z","timestamp":1770395489000},"page":"101100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medical Management of Peripheral Arterial Disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Anoop","family":"Ravilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvir.2026.101100_bib0001","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.tvir.2026.101100_bib0002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ahj.2012.12.002","article-title":"High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease","volume":"165","author":"Jones","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.tvir.2026.101100_bib0003","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/archinte.163.16.1939","article-title":"The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: The Framingham study","volume":"163","author":"Murabito","year":"2003","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.tvir.2026.101100_bib0004","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.tvir.2026.101100_bib0005","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2215\/CJN.04411007","article-title":"Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population","volume":"3","author":"Liew","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.tvir.2026.101100_bib0006","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2017.02.064","article-title":"Underuse of prevention and lifestyle counseling in patients with peripheral artery disease","volume":"69","author":"Berger","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.tvir.2026.101100_bib0007","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2014.12.043","article-title":"Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study","volume":"65","author":"Murphy","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tvir.2026.101100_bib0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2013.7231","article-title":"Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial","volume":"310","author":"McDermott","year":"2013","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.tvir.2026.101100_bib0009","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.2022.3391","article-title":"Effect of a home-based, walking exercise behavior change intervention vs usual care on walking in adults with peripheral artery disease: The MOSAIC randomized clinical trial","volume":"327","author":"Bearne","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.tvir.2026.101100_bib0010","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jvs.2004.08.049","article-title":"Influence of smoking on incidence and prevalence of peripheral arterial disease","volume":"40","author":"Willigendael","year":"2004","journal-title":"J Vasc Surg"},{"issue":"11","key":"10.1016\/j.tvir.2026.101100_bib0011","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"10037","key":"10.1016\/j.tvir.2026.101100_bib0012","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.tvir.2026.101100_bib0013","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"issue":"10338","key":"10.1016\/j.tvir.2026.101100_bib0014","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): A randomised controlled trial","volume":"399","author":"Delgado-Lista","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tvir.2026.101100_bib0015","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jvs.2020.05.066","article-title":"Hydration may reverse most symptoms of lower extremity intermittent claudication or rest pain","volume":"72","author":"Parodi","year":"2020","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.tvir.2026.101100_bib0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jvs.2017.06.101","article-title":"High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization","volume":"67","author":"Arya","year":"2018","journal-title":"J Vasc Surg"},{"issue":"Supplement_1","key":"10.1016\/j.tvir.2026.101100_bib0017","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabet Care"},{"issue":"7","key":"10.1016\/j.tvir.2026.101100_bib0018","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.tvir.2026.101100_bib0019","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.tvir.2026.101100_bib0020","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/dom.15065","article-title":"Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial","volume":"25","author":"Yi","year":"2023","journal-title":"Diabet Obes Metab"},{"issue":"4","key":"10.1016\/j.tvir.2026.101100_bib0021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.tvir.2026.101100_bib0022","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.tvir.2026.101100_bib0023","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tvir.2026.101100_bib0024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0741-5214(03)00129-0","article-title":"Platelet activation is increased in peripheral arterial disease","volume":"38","author":"Cassar","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tvir.2026.101100_bib0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","article-title":"Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: Randomized, double-blind trial","volume":"261","author":"Catalano","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.tvir.2026.101100_bib0026","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.tvir.2026.101100_bib0027","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tvir.2026.101100_bib0028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.carrev.2016.07.006","article-title":"Longterm use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials","volume":"18","author":"Fanari","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"issue":"14","key":"10.1016\/j.tvir.2026.101100_bib0029","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.tvir.2026.101100_bib0030","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tvir.2026.101100_bib0031","first-page":"366","article-title":"Cilostazol for intermittent claudication caused by peripheral artery disease","volume":"105","author":"Lauters","year":"2022","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.tvir.2026.101100_bib0032","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tvir.2026.101100_bib0033","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Heart protection study collaborative group: Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"issue":"25","key":"10.1016\/j.tvir.2026.101100_bib0034","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tvir.2026.101100_bib0035","first-page":"655","article-title":"Reduction in the risk of major adverse limb events with ezetimibe versus placebo in addition to statin therapy: Insights from the IMPROVE IT trial","volume":"44","author":"Bonaca","year":"2023","journal-title":"Eur Heart J."},{"issue":"18","key":"10.1016\/j.tvir.2026.101100_bib0036","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tvir.2026.101100_bib0037","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: Insights From the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.tvir.2026.101100_bib0038","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.tvir.2026.101100_bib0039","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCULATIONAHA.120.046524","article-title":"Peripheral artery disease and venous thromboembolic events after acute coronary syndrome: Role of lipoprotein(a) and modification by alirocumab: Prespecified analysis of the ODYSSEY OUTCOMES randomized clinical trial","volume":"141","author":"Schwartz","year":"2020","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.tvir.2026.101100_bib0040","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.tvir.2026.101100_bib0041","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"}],"container-title":["Techniques in Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108925162600003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108925162600003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:31:36Z","timestamp":1773221496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108925162600003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S108925162600003X"],"URL":"https:\/\/doi.org\/10.1016\/j.tvir.2026.101100","relation":{},"ISSN":["1089-2516"],"issn-type":[{"value":"1089-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Management of Peripheral Arterial Disease","name":"articletitle","label":"Article Title"},{"value":"Techniques in Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvir.2026.101100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101100"}}